SageView Advisory Group LLC Makes New Investment in Ardent Health, Inc. $ARDT

Key Points

• SageView Advisory Group LLC acquired a new stake in Ardent Health, Inc. worth approximately $2.33 million, acquiring 169,233 shares in the first quarter.
• Other institutional investors, including Vanguard Group and Goldman Sachs, significantly increased their holdings in Ardent Health during the same period.
• Ardent Health reported $0.52 earnings per share for the recently completed quarter, exceeding analyst expectations, with an outlook for FY 2025 set at 1.730-2.01 EPS.

SageView Advisory Group LLC purchased a new stake in shares of Ardent Health, Inc. (NYSE:ARDT - Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 169,233 shares of the company's stock, valued at approximately $2,327,000. SageView Advisory Group LLC owned 0.12% of Ardent Health as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in ARDT. Voya Investment Management LLC boosted its position in Ardent Health by 38.7% during the fourth quarter. Voya Investment Management LLC now owns 14,874 shares of the company's stock valued at $254,000 after buying an additional 4,149 shares during the period. Northern Trust Corp raised its stake in shares of Ardent Health by 7.9% during the fourth quarter. Northern Trust Corp now owns 76,191 shares of the company's stock valued at $1,301,000 after acquiring an additional 5,571 shares during the last quarter. Bank of America Corp DE raised its stake in shares of Ardent Health by 128.8% during the fourth quarter. Bank of America Corp DE now owns 168,370 shares of the company's stock valued at $2,876,000 after acquiring an additional 94,772 shares during the last quarter. Balyasny Asset Management L.P. bought a new position in shares of Ardent Health during the fourth quarter valued at about $273,000. Finally, Brevan Howard Capital Management LP bought a new position in shares of Ardent Health during the fourth quarter valued at about $198,000.

Wall Street Analysts Forecast Growth

ARDT has been the subject of several recent analyst reports. Stephens reaffirmed an "overweight" rating and set a $21.00 price objective on shares of Ardent Health in a research note on Tuesday, May 20th. JPMorgan Chase & Co. lowered their price objective on shares of Ardent Health from $18.00 to $15.00 and set a "neutral" rating for the company in a research note on Monday, August 11th. Bank of America downgraded shares of Ardent Health from a "neutral" rating to an "underperform" rating and lowered their price objective for the company from $15.50 to $14.60 in a research note on Wednesday, July 16th. Wall Street Zen raised shares of Ardent Health from a "buy" rating to a "strong-buy" rating in a research note on Saturday, August 9th. Finally, KeyCorp decreased their price target on shares of Ardent Health from $24.00 to $20.00 and set an "overweight" rating for the company in a research note on Thursday, August 7th. Nine analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Ardent Health presently has a consensus rating of "Moderate Buy" and a consensus target price of $19.33.

Ardent Health Stock Down 1.5%

ARDT traded down $0.20 during midday trading on Monday, reaching $12.88. The company's stock had a trading volume of 86,822 shares, compared to its average volume of 391,234. The firm has a market capitalization of $1.84 billion, a price-to-earnings ratio of 7.12, a PEG ratio of 5.78 and a beta of 0.29. The company has a current ratio of 2.13, a quick ratio of 2.00 and a debt-to-equity ratio of 0.66. Ardent Health, Inc. has a 1 year low of $10.10 and a 1 year high of $20.72. The stock's 50-day moving average is $12.31 and its 200-day moving average is $13.12.

Ardent Health (NYSE:ARDT - Get Free Report) last announced its quarterly earnings data on Tuesday, August 5th. The company reported $0.52 earnings per share for the quarter, topping analysts' consensus estimates of $0.30 by $0.22. The business had revenue of $1.65 billion for the quarter, compared to analysts' expectations of $1.54 billion. Ardent Health had a net margin of 4.11% and a return on equity of 16.66%. Ardent Health has set its FY 2025 guidance at 1.730-2.01 EPS. As a group, research analysts expect that Ardent Health, Inc. will post 1.23 EPS for the current year.

About Ardent Health

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.